Addition Brings Insight and Access to Federal and Private Sector Opportunities

WILMINGTON, Mass.–Implant Sciences Corporation (OTCBB:IMSC – News), a supplier of systems and sensors for the homeland security market and related industries, today announced the addition of Robert P. Liscouski to the Company’s Board of Directors.

Glenn D. Bolduc, Implant Sciences’ Chief Executive Officer, commented, “Robert Liscouski is a significant, strategic addition to our Board. His service with the Department of Homeland Security and his current advisory position to the United States Government are emblematic of the counsel we are searching for at Implant Sciences.”

Mr. Liscouski remarked, “I am pleased and excited to join the Board of Directors of Implant Sciences. After spending several months reviewing the Company’s products, I have concluded that Implant’s explosive detection solutions are best of breed in the marketplace. Implant’s technology addresses the security challenges of detecting explosives with superior technology and also provides a significant economic advantage by reducing operational costs and achieving throughput to meet the most demanding operational environments; from personnel to cargo screening deployments. I look forward to assisting the Company by introducing business opportunities that leverage its technology and intellectual property.”

Mr. Liscouski, 55, is a founder and Managing Director of 3DRS Advisors and has been President and Chief Operating Officer of Steel City Re, a firm specializing in intangible asset risk management, since 2006. Mr. Liscouski was appointed by President Bush as the first Assistant Secretary for Infrastructure Protection when the Department of Homeland Security was founded in 2003 and he served in that position until 2005. Previously, Mr. Liscouski was Director of Information Assurance at the Coca-Cola Company.

Mr. Liscouski currently serves as a member of the Intelligence Science Board, an advisory board on science and technology reporting to the Director of National Intelligence, and is a visiting fellow at the Center for Strategic and International Studies, a Washington, DC, think tank. He holds an M.P.A. from the Kennedy School of Government, Harvard University, and a B.S. in Criminal Justice from John Jay College of Criminal Justice.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for the Security, Safety and Defense (SS&D) industries. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain “forward-looking statements,” as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management’s current expectations and are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that: because the NYSE Amex has delisted our common stock, it may be extremely difficult to raise capital; if third party credit is unavailable, our working capital could be restricted and we may not be able to borrow capital; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management’s current expectations and assumptions which could differ materially from the forward-looking statements.